Results 171 to 180 of about 36,901 (236)

Prevalence, patient characteristics, and outcomes of high-dose upadacitinib in inflammatory bowel disease. [PDF]

open access: yesTher Adv Gastroenterol
Azar J   +8 more
europepmc   +1 more source

Efficacy, Safety, and Pharmacokinetics of Upadacitinib Among Patients in East Asia With Moderately to Severely Active Ulcerative Colitis: A Post Hoc Subanalysis of Randomized Phase 3 Studies. [PDF]

open access: yesJ Gastroenterol Hepatol
Wei SC   +13 more
europepmc   +1 more source

Identification of Urokinase Plasminogen Activator Receptor (uPAR)-Binding Peptides Using Phage Display: Strategy and Downstream Validation. [PDF]

open access: yesCancers (Basel)
Sloth AB   +10 more
europepmc   +1 more source

Beyond class switching in multi-refractory inflammatory bowel disease: Nine case reports and review of literature. [PDF]

open access: yesWorld J Gastrointest Pharmacol Ther
Soldera J   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy